DSpace Repository

Mass Vaccination with a Two-Dose Oral Cholera Vaccine in a Refugee Camp.

Show simple item record

dc.contributor Epicentre, Kampala, Uganda.
dc.creator Legros, D
dc.creator Paquet, C
dc.creator Perea, W
dc.creator Marty, I
dc.creator Mugisha, N K
dc.creator Royer, H
dc.creator Neira, M
dc.creator Ivanoff, B
dc.date 1999
dc.date.accessioned 2017-01-31T07:10:08Z
dc.date.available 2017-01-31T07:10:08Z
dc.identifier Mass Vaccination with a Two-Dose Oral Cholera Vaccine in a Refugee Camp. 1999, 77 (10):837-42 Bull. World Health Organ.
dc.identifier 0042-9686
dc.identifier 10593032
dc.identifier http://hdl.handle.net/10144/18815
dc.identifier http://fieldresearch.msf.org/msf/handle/10144/18815
dc.identifier Bulletin of the World Health Organization
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10144/18815
dc.description In refugee settings, the use of cholera vaccines is controversial since a mass vaccination campaign might disrupt other priority interventions. We therefore conducted a study to assess the feasibility of such a campaign using a two-dose oral cholera vaccine in a refugee camp. The campaign, using killed whole-cell/recombinant B-subunit cholera vaccine, was carried out in October 1997 among 44,000 south Sudanese refugees in Uganda. Outcome variables included the number of doses administered, the drop-out rate between the two rounds, the proportion of vaccine wasted, the speed of administration, the cost of the campaign, and the vaccine coverage. Overall, 63,220 doses of vaccine were administered. At best, 200 vaccine doses were administered per vaccination site and per hour. The direct cost of the campaign amounted to US$ 14,655, not including the vaccine itself. Vaccine coverage, based on vaccination cards, was 83.0% and 75.9% for the first and second rounds, respectively. Mass vaccination of a large refugee population with an oral cholera vaccine therefore proved to be feasible. A pre-emptive vaccination strategy could be considered in stable refugee settings and in urban slums in high-risk areas. However, the potential cost of the vaccine and the absence of quickly accessible stockpiles are major drawbacks for its large-scale use.
dc.language en
dc.publisher Published by WHO
dc.relation http://www.who.int/bulletin/en
dc.rights Archived on this site with permission of WHO
dc.title Mass Vaccination with a Two-Dose Oral Cholera Vaccine in a Refugee Camp.

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account